Publication | Open Access
Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab
21
Citations
20
References
2022
Year
Patients partially treated with teprotumumab achieve significant reduction in proptosis, CAS, and extraocular muscle restriction and maintain these improvements through the period of interruption.
| Year | Citations | |
|---|---|---|
Page 1
Page 1